niedziela, 18 sierpnia 2019
zamknij [x]
do:

Terapia komórkami macierzystymi (7)

! EN_01376355_0003 NYT
Susan L. Solomon, head of the New York Stem Cell Foundation Research Institute, in her office in New York, Feb. 21, 2019. The Food and Drug Administration has taken an industry-friendly approach toward companies using unproven cell cocktails to treat people desperate for relief from aging or damaged joints. "What if we find out it doesn't work?" she asked. "Then you've got a very large revenue stream that's going to disappear." (Demetrius Freeman/The New York Times)
MINIMALNA CENA 100USD!!!
! EN_01376355_0004 NYT
Regenexx, one of the boldest players in the growing stem cell treatment industry, in Des Moines, Jan. 28, 2019. The Food and Drug Administration has taken an industry-friendly approach toward companies using unproven cell cocktails to treat people desperate for relief from aging or damaged joints. "We have an extreme vetting," Hellickson said. (Kathryn Gamble/The New York Times)
MINIMALNA CENA 100USD!!!
! EN_01376355_0005 NYT
Jason Hellickson, chief executive of Regenexx, one of the boldest players in the growing stem cell treatment industry, in Des Moines, Jan. 28, 2019. The Food and Drug Administration has taken an industry-friendly approach toward companies using unproven cell cocktails to treat people desperate for relief from aging or damaged joints. "We have an extreme vetting," Hellickson said. (Kathryn Gamble/The New York Times)
MINIMALNA CENA 100USD!!!
! EN_01376355_0001 NYT
A doctor explains a stem cell procedure to a patient at the Nura Precision Pain Management clinic in Edina, Minn., Jan. 18, 2019. The Food and Drug Administration has taken an industry-friendly approach toward companies using unproven cell cocktails to treat people desperate for relief from aging or damaged joints. (Jenn Ackerman/The New York Times)
MINIMALNA CENA 100USD!!!
! EN_01376355_0002 NYT
A doctor injects a numbing agent into a patient's knee at the Nura Precision Pain Management clinic in Edina, Minn., for a stem cell procedure, Jan. 18, 2019. The Food and Drug Administration has taken an industry-friendly approach toward companies using unproven cell cocktails to treat people desperate for relief from aging or damaged joints. (Jenn Ackerman/The New York Times)
MINIMALNA CENA 100USD!!!
! EN_01376355_0006 NYT
An ultrasound helps guide a doctor reinject concentrated stem cells into the patient's knee at the Nura Precision Pain Management clinic in Edina, Minn., Jan. 18, 2019. The Food and Drug Administration has taken an industry-friendly approach toward companies using unproven cell cocktails to treat people desperate for relief from aging or damaged joints. (Jenn Ackerman/The New York Times)
MINIMALNA CENA 100USD!!!
! EN_01376355_0007 NYT
A doctor retrieves bone marrow from a patient's pelvic bone at the Nura Precision Pain Management clinic in Edina, Minn., for a stem cell procedure, Jan. 18, 2019. The Food and Drug Administration has taken an industry-friendly approach toward companies using unproven cell cocktails to treat people desperate for relief from aging or damaged joints. (Jenn Ackerman/The New York Times)
MINIMALNA CENA 100USD!!!
Rocznice 2018 Na wyłączność